Recent Updates
Recently added Catalysts
ARGX

argenx announces Annual General Meeting of Shareholders on May 10, 2022

Key Takeaway: argenx announces Annual General Meeting of Shareholders on May 10, 2022
Price reaction · baseline $301.6 (2022-03-28 close) · hit after-hours · 1 other ARGX headline(s) in the window, move may be shared
day 0 close
+1.9%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis

Full Press Release Details

argenx announces Annual General Meeting of Shareholders on May 10, 2022.
Last updated: Mar 29, 2022